432 related articles for article (PubMed ID: 29516878)
1. Predictive factors for pituitary response to pulsatile GnRH therapy in patients with congenital hypogonadotropic hypogonadism.
Mao JF; Wang X; Zheng JJ; Liu ZX; Xu HL; Huang BK; Nie M; Wu XY
Asian J Androl; 2018; 20(4):319-323. PubMed ID: 29516878
[TBL] [Abstract][Full Text] [Related]
2. Efficacy of Pulsatile Gonadotropin-Releasing Hormone Therapy in Male Patients: Comparison between Pituitary Stalk Interruption Syndrome and Congenital Hypogonadotropic Hypogonadism.
Huang Q; Mao J; Wang X; Yu B; Ma W; Ji W; Zhu Y; Zhang R; Sun B; Zhang J; Nie M; Wu X
Endocr Pract; 2022 May; 28(5):521-527. PubMed ID: 35218954
[TBL] [Abstract][Full Text] [Related]
3. Two-year comparison of testicular responses to pulsatile gonadotropin-releasing hormone and exogenous gonadotropins from the inception of therapy in men with isolated hypogonadotropic hypogonadism.
Liu L; Banks SM; Barnes KM; Sherins RJ
J Clin Endocrinol Metab; 1988 Dec; 67(6):1140-5. PubMed ID: 3142911
[TBL] [Abstract][Full Text] [Related]
4. Pulsatile gonadotropin-releasing hormone therapy is associated with earlier spermatogenesis compared to combined gonadotropin therapy in patients with congenital hypogonadotropic hypogonadism.
Mao JF; Liu ZX; Nie M; Wang X; Xu HL; Huang BK; Zheng JJ; Min L; Kaiser UB; Wu XY
Asian J Androl; 2017; 19(6):680-685. PubMed ID: 28051040
[TBL] [Abstract][Full Text] [Related]
5. Pulsatile GnRH Therapy May Restore Hypothalamus-Pituitary-Testis Axis Function in Patients With Congenital Combined Pituitary Hormone Deficiency: A Prospective, Self-Controlled Trial.
Zheng J; Mao J; Xu H; Wang X; Huang B; Liu Z; Cui M; Xiong S; Ma W; Min L; Kaiser UB; Nie M; Wu X
J Clin Endocrinol Metab; 2017 Jul; 102(7):2291-2300. PubMed ID: 28368486
[TBL] [Abstract][Full Text] [Related]
6. Gonadotropin-releasing hormone (GnRH) analog suppression renders polycystic ovarian disease patients more susceptible to ovulation induction with pulsatile GnRH.
Filicori M; Campaniello E; Michelacci L; Pareschi A; Ferrari P; Bolelli G; Flamigni C
J Clin Endocrinol Metab; 1988 Feb; 66(2):327-33. PubMed ID: 3123511
[TBL] [Abstract][Full Text] [Related]
7. Pulsatile Gonadotropin-Releasing Hormone Therapy Is Associated With Better Spermatogenic Outcomes than Gonadotropin Therapy in Patients With Pituitary Stalk Interruption Syndrome.
Zhang J; Zhu Y; Zhang R; Liu H; Sun B; Zhang W; Wang X; Nie M; Mao J; Wu X
Endocr Pract; 2024 Feb; 30(2):146-154. PubMed ID: 38029930
[TBL] [Abstract][Full Text] [Related]
8. Congenital idiopathic hypogonadotropic hypogonadism: evidence of defects in the hypothalamus, pituitary, and testes.
Sykiotis GP; Hoang XH; Avbelj M; Hayes FJ; Thambundit A; Dwyer A; Au M; Plummer L; Crowley WF; Pitteloud N
J Clin Endocrinol Metab; 2010 Jun; 95(6):3019-27. PubMed ID: 20382682
[TBL] [Abstract][Full Text] [Related]
9. Hypogonadotropic hypogonadism in severe beta-thalassemia: effect of chelation and pulsatile gonadotropin-releasing hormone therapy.
Wang C; Tso SC; Todd D
J Clin Endocrinol Metab; 1989 Mar; 68(3):511-6. PubMed ID: 2493034
[TBL] [Abstract][Full Text] [Related]
10. Non-responsiveness of serum gonadotropins and testosterone to pulsatile GnRH in hemochromatosis suggesting a pituitary defect.
Duranteau L; Chanson P; Blumberg-Tick J; Thomas G; Brailly S; Lubetzki J; Schaison G; Bouchard P
Acta Endocrinol (Copenh); 1993 Apr; 128(4):351-4. PubMed ID: 8498154
[TBL] [Abstract][Full Text] [Related]
11. Pulsatile luteinizing hormone-releasing hormone treatment of male hypogonadotropic hypogonadism.
Aulitzky W; Frick J; Galvan G
Fertil Steril; 1988 Sep; 50(3):480-6. PubMed ID: 3137102
[TBL] [Abstract][Full Text] [Related]
12. Pulsatile gonadotropin secretion after discontinuation of long term gonadotropin-releasing hormone (GnRH) administration in a subset of GnRH-deficient men.
Finkelstein JS; Spratt DI; O'Dea LS; Whitcomb RW; Klibanski A; Schoenfeld DA; Crowley WF
J Clin Endocrinol Metab; 1989 Aug; 69(2):377-85. PubMed ID: 2502554
[TBL] [Abstract][Full Text] [Related]
13. Reversal of idiopathic hypogonadotropic hypogonadism: a cohort study in Chinese patients.
Mao JF; Xu HL; Duan J; Chen RR; Li L; Li B; Nie M; Min L; Zhang HB; Wu XY
Asian J Androl; 2015; 17(3):497-502. PubMed ID: 25578938
[TBL] [Abstract][Full Text] [Related]
14. Differentiation of male hypogonadotropic hypogonadism and constitutional delay of puberty by pulsatile administration of gonadotropin-releasing hormone.
Partsch CJ; Hermanussen M; Sippell WG
J Clin Endocrinol Metab; 1985 Jun; 60(6):1196-203. PubMed ID: 3923024
[TBL] [Abstract][Full Text] [Related]
15. Delayed puberty in males with beta-thalassemia major: pulsatile gonadotropin-releasing hormone administration induces changes in gonadotropin isoform profiles and an increase in sex steroids.
Valenti S; Giusti M; McGuinness D; Guido R; Mori PG; Giordano G; Dahl KD
Eur J Endocrinol; 1995 Jul; 133(1):48-56. PubMed ID: 7627337
[TBL] [Abstract][Full Text] [Related]
16. Changes in levels of testosterone, insulin sensitivity and metabolic profiles during GnRH therapy: Reciprocity between insulin sensitivity and pituitary responsiveness to GnRH in teenage and young male patients with congenital hypogonadotropic hypogonadism.
Fan HQ; Wang YC; He W; Zhou HW; Yang T
Clin Endocrinol (Oxf); 2022 Dec; 97(6):783-791. PubMed ID: 36181235
[TBL] [Abstract][Full Text] [Related]
17. Predictors of outcome of long-term GnRH therapy in men with idiopathic hypogonadotropic hypogonadism.
Pitteloud N; Hayes FJ; Dwyer A; Boepple PA; Lee H; Crowley WF
J Clin Endocrinol Metab; 2002 Sep; 87(9):4128-36. PubMed ID: 12213860
[TBL] [Abstract][Full Text] [Related]
18. [Effect of pulsatile GnRH therapy on pituitary-testicular axis function in male patients with pituitary stalk interruption syndrome].
Zheng JJ; Mao JF; Wu XY; Wang X; Liu ZX; Huang BK
Zhonghua Yi Xue Za Zhi; 2016 Jun; 96(21):1668-72. PubMed ID: 27290707
[TBL] [Abstract][Full Text] [Related]
19. Idiopathic hypogonadotropic hypogonadism in men: dependence of the hormone responses to gonadotropin-releasing hormone (GnRH) on the magnitude of the endogenous GnRH secretory defect.
Barkan AL; Reame NE; Kelch RP; Marshall JC
J Clin Endocrinol Metab; 1985 Dec; 61(6):1118-25. PubMed ID: 3932448
[TBL] [Abstract][Full Text] [Related]
20. Pulsatile gonadotropin-releasing hormone treatment of men with idiopathic hypogonadotropic hypogonadism.
Christiansen P; Skakkebaek NE
Horm Res; 2002; 57(1-2):32-6. PubMed ID: 12006717
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
